Using more objective measures such as radi-
ography to look at any change in OA progression, refining the study inclusion criteria, providing longer
follow-up periods and trying to establish a clear
biochemical model for glucosamine may enable more
definitive conclusions to be drawn so that clinicians can
confidently advise their patients based on the best available evidence.